Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Tahtinen S, Feola S, Capasso C, Laustio N, et al. Cancer Res 2020;80:2575-2585.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tahtinen S, Feola S, Capasso C, Laustio N, et al. Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer Res 2020;80:2575-2585.
PMID: 32107211